 Kristen Nordenholz
Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Embolism | 17 | 2021 | 183 | 2.600 |
Why?
| | Venous Thromboembolism | 7 | 2022 | 236 | 0.960 |
Why?
| | Emergency Service, Hospital | 15 | 2021 | 1970 | 0.790 |
Why?
| | Fibrin Fibrinogen Degradation Products | 7 | 2016 | 83 | 0.780 |
Why?
| | Anticoagulants | 4 | 2021 | 587 | 0.470 |
Why?
| | Antithrombins | 1 | 2013 | 57 | 0.440 |
Why?
| | Emergency Medicine | 3 | 2023 | 263 | 0.440 |
Why?
| | Tissue Plasminogen Activator | 4 | 2017 | 245 | 0.430 |
Why?
| | Fibrinolytic Agents | 4 | 2017 | 256 | 0.420 |
Why?
| | Emergency Treatment | 1 | 2013 | 123 | 0.410 |
Why?
| | gamma-Glutamyltransferase | 1 | 2012 | 47 | 0.410 |
Why?
| | Venous Thrombosis | 3 | 2016 | 143 | 0.400 |
Why?
| | Hemorrhage | 2 | 2014 | 673 | 0.350 |
Why?
| | Patient Care Team | 1 | 2014 | 546 | 0.330 |
Why?
| | Oximetry | 1 | 2009 | 98 | 0.320 |
Why?
| | Healthcare Disparities | 1 | 2014 | 515 | 0.310 |
Why?
| | Patient Acceptance of Health Care | 1 | 2014 | 716 | 0.300 |
Why?
| | Diagnosis, Computer-Assisted | 1 | 2008 | 68 | 0.290 |
Why?
| | Burnout, Professional | 2 | 2023 | 340 | 0.290 |
Why?
| | Thromboembolism | 1 | 2007 | 101 | 0.280 |
Why?
| | Blood Proteins | 1 | 2008 | 253 | 0.270 |
Why?
| | Sensitivity and Specificity | 8 | 2016 | 1885 | 0.260 |
Why?
| | Diagnostic Imaging | 2 | 2008 | 311 | 0.260 |
Why?
| | Prospective Studies | 14 | 2016 | 6818 | 0.230 |
Why?
| | Biomarkers | 3 | 2017 | 3736 | 0.210 |
Why?
| | Middle Aged | 20 | 2022 | 29112 | 0.200 |
Why?
| | Mass Screening | 2 | 2021 | 1119 | 0.200 |
Why?
| | Severity of Illness Index | 1 | 2009 | 2848 | 0.190 |
Why?
| | Heroin Dependence | 1 | 2000 | 20 | 0.170 |
Why?
| | Muscarinic Antagonists | 1 | 2000 | 29 | 0.170 |
Why?
| | Renal Insufficiency | 1 | 2022 | 155 | 0.170 |
Why?
| | Male | 24 | 2022 | 60793 | 0.170 |
Why?
| | Drug Contamination | 1 | 2000 | 59 | 0.170 |
Why?
| | Humans | 33 | 2023 | 125132 | 0.170 |
Why?
| | Female | 24 | 2022 | 64890 | 0.160 |
Why?
| | Poisoning | 1 | 2000 | 113 | 0.160 |
Why?
| | Thrombosis | 1 | 2022 | 319 | 0.160 |
Why?
| | Adult | 16 | 2021 | 33168 | 0.150 |
Why?
| | Respiratory Insufficiency | 1 | 2022 | 309 | 0.150 |
Why?
| | Acute Disease | 3 | 2017 | 1016 | 0.150 |
Why?
| | Predictive Value of Tests | 4 | 2015 | 1992 | 0.140 |
Why?
| | Rivaroxaban | 2 | 2021 | 216 | 0.140 |
Why?
| | Dyspnea | 2 | 2015 | 220 | 0.140 |
Why?
| | Risk Factors | 8 | 2021 | 9549 | 0.130 |
Why?
| | Abdominal Injuries | 1 | 1997 | 120 | 0.130 |
Why?
| | Ultrasonography | 2 | 2016 | 757 | 0.130 |
Why?
| | Physicians | 1 | 2023 | 836 | 0.120 |
Why?
| | Quality of Life | 3 | 2015 | 2580 | 0.120 |
Why?
| | Efficiency, Organizational | 1 | 2015 | 135 | 0.120 |
Why?
| | Dabigatran | 1 | 2013 | 29 | 0.110 |
Why?
| | beta-Alanine | 1 | 2013 | 22 | 0.110 |
Why?
| | Heparin, Low-Molecular-Weight | 1 | 2013 | 30 | 0.110 |
Why?
| | Wounds, Nonpenetrating | 1 | 1997 | 287 | 0.110 |
Why?
| | Fibrinolysis | 1 | 2015 | 175 | 0.110 |
Why?
| | Aged | 9 | 2021 | 20859 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 2539 | 0.110 |
Why?
| | Radiology | 1 | 2016 | 205 | 0.110 |
Why?
| | Thiophenes | 1 | 2013 | 107 | 0.110 |
Why?
| | Morpholines | 1 | 2013 | 108 | 0.110 |
Why?
| | Pyridones | 1 | 2013 | 120 | 0.100 |
Why?
| | Benzimidazoles | 1 | 2013 | 142 | 0.100 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2015 | 242 | 0.100 |
Why?
| | Probability | 2 | 2014 | 318 | 0.100 |
Why?
| | Diagnosis, Differential | 3 | 2015 | 1431 | 0.100 |
Why?
| | Administration, Oral | 1 | 2013 | 785 | 0.090 |
Why?
| | Radiation Injuries | 1 | 2012 | 138 | 0.090 |
Why?
| | Decision Support Techniques | 1 | 2015 | 395 | 0.090 |
Why?
| | Retrospective Studies | 5 | 2022 | 13708 | 0.090 |
Why?
| | Pyrazoles | 1 | 2013 | 380 | 0.090 |
Why?
| | Heparin | 1 | 2012 | 236 | 0.090 |
Why?
| | Medical History Taking | 1 | 2010 | 128 | 0.080 |
Why?
| | False Negative Reactions | 1 | 2008 | 59 | 0.080 |
Why?
| | Physical Examination | 1 | 2010 | 256 | 0.080 |
Why?
| | Peroxidase | 1 | 2008 | 184 | 0.080 |
Why?
| | Area Under Curve | 1 | 2008 | 305 | 0.070 |
Why?
| | Research Design | 1 | 2013 | 1035 | 0.070 |
Why?
| | Nephelometry and Turbidimetry | 1 | 2007 | 15 | 0.070 |
Why?
| | HIV Infections | 1 | 2021 | 2588 | 0.070 |
Why?
| | Quality of Health Care | 1 | 2012 | 658 | 0.070 |
Why?
| | Critical Care | 1 | 2012 | 563 | 0.070 |
Why?
| | Inflammation | 1 | 2017 | 2612 | 0.070 |
Why?
| | C-Reactive Protein | 1 | 2008 | 381 | 0.070 |
Why?
| | Observer Variation | 1 | 2007 | 330 | 0.070 |
Why?
| | Algorithms | 2 | 2008 | 1618 | 0.070 |
Why?
| | Electrocardiography | 1 | 2009 | 637 | 0.070 |
Why?
| | Logistic Models | 4 | 2012 | 2040 | 0.060 |
Why?
| | Cohort Studies | 1 | 2014 | 5348 | 0.060 |
Why?
| | Odds Ratio | 3 | 2012 | 1050 | 0.060 |
Why?
| | Risk Assessment | 2 | 2012 | 3274 | 0.050 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2022 | 93 | 0.050 |
Why?
| | Faculty | 1 | 2022 | 142 | 0.050 |
Why?
| | Decision Trees | 1 | 2021 | 95 | 0.050 |
Why?
| | Indiana | 1 | 2020 | 30 | 0.050 |
Why?
| | Symptom Assessment | 1 | 2022 | 125 | 0.050 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2022 | 229 | 0.040 |
Why?
| | Personal Satisfaction | 1 | 2022 | 195 | 0.040 |
Why?
| | Cough | 1 | 2021 | 108 | 0.040 |
Why?
| | Mid-Atlantic Region | 1 | 2000 | 4 | 0.040 |
Why?
| | Heroin | 1 | 2000 | 20 | 0.040 |
Why?
| | Adolescent | 4 | 2013 | 19411 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2020 | 269 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1725 | 0.040 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2000 | 144 | 0.040 |
Why?
| | Treatment Outcome | 4 | 2021 | 9790 | 0.040 |
Why?
| | Fever | 1 | 2021 | 294 | 0.040 |
Why?
| | United States | 4 | 2021 | 13613 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2010 | 341 | 0.040 |
Why?
| | Survival Analysis | 1 | 2021 | 1341 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2009 | 1880 | 0.040 |
Why?
| | Ambulatory Care | 1 | 2022 | 511 | 0.040 |
Why?
| | Convalescence | 1 | 2017 | 16 | 0.040 |
Why?
| | Health Personnel | 1 | 2023 | 620 | 0.040 |
Why?
| | Peritoneal Lavage | 1 | 1997 | 8 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2012 | 1561 | 0.040 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 1997 | 27 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2000 | 334 | 0.040 |
Why?
| | Length of Stay | 1 | 2021 | 1077 | 0.030 |
Why?
| | Antiviral Agents | 1 | 2022 | 673 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2007 | 6936 | 0.030 |
Why?
| | Databases, Factual | 1 | 2021 | 1298 | 0.030 |
Why?
| | Coronavirus Infections | 1 | 2021 | 347 | 0.030 |
Why?
| | Registries | 2 | 2021 | 2050 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1434 | 0.030 |
Why?
| | Suicide, Attempted | 1 | 1997 | 335 | 0.030 |
Why?
| | Angiography | 1 | 2015 | 182 | 0.030 |
Why?
| | Wounds, Gunshot | 1 | 1997 | 193 | 0.030 |
Why?
| | Lower Extremity | 1 | 2016 | 356 | 0.030 |
Why?
| | Contrast Media | 1 | 2015 | 388 | 0.030 |
Why?
| | Shock | 1 | 2014 | 97 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2012 | 48 | 0.020 |
Why?
| | Echocardiography | 1 | 2015 | 609 | 0.020 |
Why?
| | Blood Coagulation Tests | 1 | 2012 | 59 | 0.020 |
Why?
| | APACHE | 1 | 2012 | 65 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2022 | 4854 | 0.020 |
Why?
| | Single-Blind Method | 1 | 2012 | 286 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 429 | 0.020 |
Why?
| | Factor Xa Inhibitors | 1 | 2012 | 142 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1006 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2022 | 5062 | 0.020 |
Why?
| | Child | 2 | 2007 | 20014 | 0.020 |
Why?
| | Bundle-Branch Block | 1 | 2009 | 34 | 0.020 |
Why?
| | Radiography | 1 | 2012 | 893 | 0.020 |
Why?
| | Chest Pain | 1 | 2010 | 95 | 0.020 |
Why?
| | Thrombophilia | 1 | 2010 | 70 | 0.020 |
Why?
| | Likelihood Functions | 1 | 2009 | 141 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1997 | 833 | 0.020 |
Why?
| | Tachycardia | 1 | 2009 | 58 | 0.020 |
Why?
| | Clinical Competence | 1 | 2016 | 1013 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2012 | 1366 | 0.020 |
Why?
| | Databases as Topic | 1 | 2008 | 78 | 0.020 |
Why?
| | ROC Curve | 1 | 2008 | 501 | 0.020 |
Why?
| | Age Factors | 1 | 2012 | 3152 | 0.020 |
Why?
| | Time Factors | 1 | 2015 | 6780 | 0.010 |
Why?
| | Quality Improvement | 1 | 2012 | 1020 | 0.010 |
Why?
| | Sex Factors | 1 | 2010 | 1901 | 0.010 |
Why?
| | Obesity | 1 | 2015 | 2805 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2012 | 2325 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 11385 | 0.010 |
Why?
| | Age Distribution | 1 | 1997 | 384 | 0.010 |
Why?
| | Sex Distribution | 1 | 1997 | 384 | 0.010 |
Why?
| | Self-Injurious Behavior | 1 | 1997 | 133 | 0.010 |
Why?
| | Survival Rate | 1 | 1997 | 1799 | 0.010 |
Why?
| | Firearms | 1 | 1997 | 296 | 0.010 |
Why?
| | Incidence | 1 | 1997 | 2578 | 0.010 |
Why?
| | Mental Disorders | 1 | 1997 | 976 | 0.010 |
Why?
| | Child, Preschool | 1 | 1997 | 9938 | 0.000 |
Why?
|
|
Nordenholz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|